Jan 14, 2020   SOURCE: PR NewsWire

Antifibrinolytic Drugs Market to Garner $19.33 Bn, Globally, By 2026 at 4.5% CAGR, Says Allied Market Research

PORTLAND, Oregon, Jan. 14, 2020 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Antifibrinolytic Drugs Market by Indication (Gynecology, Hereditary Angiedema, Fibrinolytic Response Testing, Surgeries, and Others) and End user (Hospitals & Clinics, Ambulatory Surgical Centers, and Healthcare Specialty Process): Global Opportunity Analysis and Industry Forecast, 2019-2026". According to the report, the global antifibrinolytic drugs industry was pegged at $13.59 billion in 2018 and is projected to reach $19.33 billion by 2026, registering a CAGR of 4.5% from 2019 to 2026.

https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Chief reasons for market fluctuations

Rise in severe road accidents and significant increase in surgical procedures have boosted the growth of the global antifibrinolytic drugs market. However, high cost of these drugs hampers the market growth. On the contrary, untapped potential in developing countries is expected to create lucrative opportunities in the near future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6279

The gynecology segment dominated the market

The gynecology segment held the largest share in 2018, contributing to nearly one-third of the global antifibrinolytic drugs market, owing to increased adoption of these drugs to prevent menorrhagia i.e. heavy menstrual flow. However, the surgeries segment is expected to manifest the fastest CAGR of 5.9% during the study period, owing to significant increase in the number of surgeries being performed across the globe.

The trauma centers segment to manifest the fastest growth

The trauma center segment is anticipated to portray the fastest CAGR of 5.1% during the forecast period, owing to remarkable increase in road accidents globally. However, the hospitals and clinics segment held the largest share in 2018, accounting for nearly half of the global antifibrinolytic drugs market share. This is due to increased usage of these drugs in hospitals as most of the surgeries such as cardiovascular and neurosurgeries are performed in hospitals.

North America region held the lion's share

The global antifibrinolytic drugs market across North America held the largest share in 2018, contributing to more than two-fifths of the market, owing to surge in surgeries in the region. However, the market across the Asia-Pacific region is expected to register the fastest 6.1% during the forecast period, owing to increase in road accidents in this region.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6279

Major market players

    --  Xanodyne Pharmaceuticals
    --  ACIC Fine Chems
    --  Aurobindo Pharma Ltd.
    --  Amerigen Pharms Ltd
    --  Akorn
    --  Pfizer (GenMed)
    --  Mylan
    --  Zydus Cadila
    --  Sanofi
    --  Takeda

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Antihypertensive Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019-2026

Antihyperlipidemic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019-2026

Digital Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2017-2025

Sleep Aids Market: Global Opportunity Analysis and Industry Forecast, 2017-2025

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

View original content:http://www.prnewswire.com/news-releases/antifibrinolytic-drugs-market-to-garner-19-33-bn-globally-by-2026-at-4-5-cagr-says-allied-market-research-300986564.html

SOURCE Allied Market Research